Literature DB >> 10493530

The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.

G Badcock1, C Pigott, J Goepel, P W Andrews.   

Abstract

Human embryonal carcinoma (EC) cells are the stem cells of teratocarcinomas, and they are key components of germ cell tumors (GCTs). They express several high molecular weight glycoprotein antigens that are down-regulated upon differentiation. One of these antigens, defined by monoclonal antibody TRA-1-60, can be detected in the serum of GCT patients and provides a useful complement to the established serum markers human chorionic gonadotropin and alpha-fetoprotein, especially in those patients without elevated serum human chorionic gonadotropin or alpha-fetoprotein. To examine the relationship of the TRA-1-60-defined antigen to similar antigens defined by other monoclonal antibodies, we have carried out comparative Western blot and immunoprecipitation analyses of human GCT-derived cell lines with monoclonal antibodies TRA-1-60, TRA-1-81, GCTM2, and K21. The TRA-1-60 antigen was detected by Western blot analysis in extracts of all human EC cell lines and in clinical specimens of GCT tested as a diffuse band with a molecular weight of >200,000. A similar but noticeably fainter band was detected in GCT composed of seminoma only. The antigen was not expressed by GCT-derived lines without an EC phenotype. Affinity bead-purified TRA-1-60, TRA-1-81, GCTM2 and K21 antigens reacted in Western blot analysis with each of the other antibodies tested, indicating that the epitopes recognized by each antibody are carried by the same molecular species. This molecule could be metabolically labeled with inorganic [35S]sulfate and was degraded by keratanase. Glycopeptides produced from affinity-purified TRA-1-60 antigen by extensive digestion with Pronase exhibited a molecular weight in excess of 10,000 and were degraded by keratanase. The TRA-1-60 epitope was destroyed by digestion with neuraminidase, but the epitopes defined by TRA-1-81, GCTM2, and K21 were not. Our results indicate that human EC cells generally express a cell surface sialylated keratan sulfate proteoglycan that is subject to modification to yield a variety of epitopes, one of which is recognized by the monoclonal antibody TRA-1-60. Sensitivity to milk alkaline digestion suggests that the oligosaccharides of this proteoglycan are O-linked to a core polypeptide.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493530

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Biochemical properties of a keratan sulphate/chondroitin sulphate proteoglycan expressed in primate pluripotent stem cells.

Authors:  Susan Cooper; William Bennett; Jessica Andrade; Benjamin E Reubinoff; James Thomson; Martin F Pera
Journal:  J Anat       Date:  2002-03       Impact factor: 2.610

Review 2.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 3.  Reviewing and updating the major molecular markers for stem cells.

Authors:  Raquel Calloni; Elvira Alicia Aparicio Cordero; João Antonio Pêgas Henriques; Diego Bonatto
Journal:  Stem Cells Dev       Date:  2013-01-22       Impact factor: 3.272

Review 4.  Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.

Authors:  Hidenao Toyoda; Yuko Nagai; Aya Kojima; Akiko Kinoshita-Toyoda
Journal:  Glycoconj J       Date:  2017-01-11       Impact factor: 2.916

5.  Surface antigens of human embryonic stem cells: changes upon differentiation in culture.

Authors:  Jonathan S Draper; Christine Pigott; James A Thomson; Peter W Andrews
Journal:  J Anat       Date:  2002-03       Impact factor: 2.610

6.  Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.

Authors:  Ilkyun Im; Ye Seul Son; Kwang Bo Jung; Insoo Kang; Boon-Eng Teh; Kyung-Bok Lee; Mi-Young Son; Janghwan Kim
Journal:  J Biol Chem       Date:  2019-09-30       Impact factor: 5.157

Review 7.  Carbohydrate engineered cells for regenerative medicine.

Authors:  Jian Du; Kevin J Yarema
Journal:  Adv Drug Deliv Rev       Date:  2010-02-01       Impact factor: 15.470

8.  Detecting TRA-1-60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent.

Authors:  Jordan M White; Akhila N Kuda-Wedagedara; Madison N Wicker; Daniel E Spratt; William M Schopperle; Elisabeth Heath; Nerissa T Viola
Journal:  Mol Pharm       Date:  2020-02-28       Impact factor: 4.939

Review 9.  Embryoglycan: a highly branched poly-N-acetyllactosamine in pluripotent stem cells and early embryonic cells.

Authors:  Takashi Muramatsu
Journal:  Glycoconj J       Date:  2016-05-17       Impact factor: 2.916

10.  Assignment of the 2.03 ppm resonance in in vivo 1H MRS of human brain tumour cystic fluid: contribution of macromolecules.

Authors:  A P Candiota; C Majós; A Bassols; M E Cabañas; J J Acebes; M R Quintero; C Arús
Journal:  MAGMA       Date:  2004-08-31       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.